Table 1: The correlation of results obtained by; a) SPRCA/HA and Pcat; b) SPRCA/HA and pCTT.

Antibody

Comparing Methods

Spearman’s rho

P-Value

Strength of Correlation

Association

Direction of Correlation

a) SPRCA/HA and pCAT

IgM

Anti-A

HA-pCAT(1+)

0.45

< 0.05

Moderate

Significant

Positive

Anti-B

HA-pCAT(1+)

0.42

< 0.05

Moderate

Significant

Positive

IgG

Anti-A

SPRCA-pCAT(1+)

0.52

< 0.05

Moderate

Significant

Positive

Anti-B

SPRCA- pCAT(1+)

0.58

< 0.05

Moderate

Significant

Positive

IgM

Anti-A

HA - pCAT(2+)

0.43

< 0.05

Moderate

Significant

Positive

Anti-B

HA - pCAT(2+)

0.41

< 0.05

Moderate

Significant

Positive

IgG

Anti-A

SPRCA - pCAT(2+)

0.51

< 0.05

Moderate

Significant

Positive

Anti-B

SPRCA- pCAT(2+)

0.59

< 0.05

Moderate

Significant

Positive

IgM

Anti-A

HA - pCAT(3+)

0.43

< 0.05

Moderate

Significant

Positive

Anti-B

HA- pCAT(3+)

0.4

< 0.05

Moderate

Significant

Positive

IgG

Anti-A

SPRCA - pCAT(3+)

0.53

< 0.05

Moderate

Significant

Positive

Anti-B

SPRCA- pCAT(3+)

0.58

< 0.05

Moderate

Significant

Positive

b) SPRCA/HA and pCTT

IgM

Anti-A

HA - pCTT(1+)

0.41

< 0.05

Moderate

Significant

Positive

Anti-B

HA- pCTT(1+)

0.42

< 0.05

Moderate

Significant

Positive

IgG

Anti-A

SPRCA -pCTT(1+)

0.47

< 0.05

Moderate

Significant

Positive

Anti-B

SPRCA-pCTT(1+)

0.48

< 0.05

Moderate

Significant

Positive

CTT: Pre HI treatment performed by CTT; CAT: Pre HI treatment performed by CAT; pCTT: Post HI treatment performed by CTT; pCAT: Post HI treatment performed by CAT